BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7753832)

  • 1. Inhibition of AP-1 binding and transcription by gold and selenium involving conserved cysteine residues in Jun and Fos.
    Handel ML; Watts CK; deFazio A; Day RO; Sutherland RL
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4497-501. PubMed ID: 7753832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of AP-1 DNA binding by nitric oxide involving conserved cysteine residues in Jun and Fos.
    Nikitovic D; Holmgren A; Spyrou G
    Biochem Biophys Res Commun; 1998 Jan; 242(1):109-12. PubMed ID: 9439619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-penicillamine causes free radical-dependent inactivation of activator protein-1 DNA binding.
    Handel ML; Watts CK; Sivertsen S; Day RO; Sutherland RL
    Mol Pharmacol; 1996 Sep; 50(3):501-5. PubMed ID: 8794887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin derivatives inhibit the formation of Jun-Fos-DNA complex independently of their conserved cysteine residues.
    Park CH; Lee JH; Yang CH
    J Biochem Mol Biol; 2005 Jul; 38(4):474-80. PubMed ID: 16053715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AP-1 DNA-binding activity is inhibited by selenite and selenodiglutathione.
    Spyrou G; Björnstedt M; Kumar S; Holmgren A
    FEBS Lett; 1995 Jul; 368(1):59-63. PubMed ID: 7615089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-range electrostatic interactions influence the orientation of Fos-Jun binding at AP-1 sites.
    Ramirez-Carrozzi VR; Kerppola TK
    J Mol Biol; 2001 Jan; 305(3):411-27. PubMed ID: 11152600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of DNA bending and oriented heterodimer binding by the basic leucine zipper domains of Fos and Jun.
    Leonard DA; Rajaram N; Kerppola TK
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4913-8. PubMed ID: 9144164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coactivator MBF1 preserves the redox-dependent AP-1 activity during oxidative stress in Drosophila.
    Jindra M; Gaziova I; Uhlirova M; Okabe M; Hiromi Y; Hirose S
    EMBO J; 2004 Sep; 23(17):3538-47. PubMed ID: 15306851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fos and Jun inhibit estrogen-induced transcription of the human progesterone receptor gene through an activator protein-1 site.
    Petz LN; Ziegler YS; Schultz JR; Nardulli AM
    Mol Endocrinol; 2004 Mar; 18(3):521-32. PubMed ID: 14684847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of IL-1-induced gingival collagenase gene expression by activator protein-1 (c-Fos/c-Jun).
    Hamid QA; Reddy PJ; Tewari M; Uematsu S; Tuncay OC; Tewari DS
    Cytokine; 2000 Nov; 12(11):1609-19. PubMed ID: 11052811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.
    Bossis G; Malnou CE; Farras R; Andermarcher E; Hipskind R; Rodriguez M; Schmidt D; Muller S; Jariel-Encontre I; Piechaczyk M
    Mol Cell Biol; 2005 Aug; 25(16):6964-79. PubMed ID: 16055710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene.
    Manna PR; Eubank DW; Stocco DM
    Mol Endocrinol; 2004 Mar; 18(3):558-73. PubMed ID: 14673133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of activator protein-1 by sulforaphane involves interaction with cysteine in the cFos DNA-binding domain: implications for chemoprevention of UVB-induced skin cancer.
    Dickinson SE; Melton TF; Olson ER; Zhang J; Saboda K; Bowden GT
    Cancer Res; 2009 Sep; 69(17):7103-10. PubMed ID: 19671797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA.
    Chen L; Glover JN; Hogan PG; Rao A; Harrison SC
    Nature; 1998 Mar; 392(6671):42-8. PubMed ID: 9510247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
    Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
    Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
    Suzukawa K; Colburn NH
    Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E1A + cHa-ras transformed rat embryo fibroblast cells are characterized by high and constitutive DNA binding activities of AP-1 dimers with significantly altered composition.
    Pospelova TV; Medvedev AV; Kukushkin AN; Svetlikova SB; van der Eb AJ; Dorsman JC; Pospelov VA
    Gene Expr; 1999; 8(1):19-32. PubMed ID: 10543728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA-binding domains of Fos and Jun do not induce DNA curvature: an investigation with solution and gel methods.
    Sitlani A; Crothers DM
    Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1404-9. PubMed ID: 9465027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acid residues required for physical and cooperative transcriptional interaction of STAT3 and AP-1 proteins c-Jun and c-Fos.
    Ginsberg M; Czeko E; Müller P; Ren Z; Chen X; Darnell JE
    Mol Cell Biol; 2007 Sep; 27(18):6300-8. PubMed ID: 17636030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of genistein on c-Jun, c-Fos and Fos-B of AP-1 subunits expression in skin keratinocytes, fibroblasts and keloid fibroblasts cultured in vitro.
    Jurzak M; Adamczyk K
    Acta Pol Pharm; 2013; 70(2):205-13. PubMed ID: 23614275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.